Skip to content
Screener

Xtant Medical Holdings XTNT Q2 2025 earnings

Reported August 12, 2025 · Before market open

Revenue$35.4MBeat by $4.2M
EPS$0.02Beat by $0.03
Revenue estimate$31.2M
EPS estimate-$0.01

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$25.5M
EPS estimate-$0.03

Financials

Q2 2025

Income statement

See full
Revenue$35.4M+18.3%
Gross profit$24.3M+30.7%
Operating income$4.6M+257%
Net income$3.6M+192%
EPS (diluted)$0.02+167%

Balance sheet

See full
Cash & equivalents$7.0M+28.5%
Total debt$25.1M+8.6%
Total equity$48.5M+7.8%
Total assets$103.5M+8.3%

Cash flow

See full
Operating cash flow$1.3M+125%
CapEx$366.0K-35.1%
Free cash flow$910.0K+116%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$88.61M+8.0%
Enterprise value$106.64M+7.0%
P/S0.7×0.0×

Profitability

See full
Gross margin60.2%-1.5pp
Operating margin0%0.0pp
Net margin-3.6%—
FCF margin-2.2%-1.0pp

Returns & leverage

See full
Return on equity-9.8%—
Debt / equity0.5×0.0×
Current ratio2.5×0.0×

Segments

By product

See full
Orthobiologics$19.4M+20.1%
Spinal Implant$11.1M-19.9%

FAQ

When did Xtant Medical Holdings report Q2 2025 earnings?
Xtant Medical Holdings (XTNT) reported Q2 2025 earnings on August 12, 2025 before market open.
What were Xtant Medical Holdings's Q2 2025 revenue and EPS?
Xtant Medical Holdings reported revenue of $35.4M and eps of $0.02 for Q2 2025.
Did Xtant Medical Holdings beat estimates in Q2 2025?
Revenue beat the consensus estimate of $31.2M by $4.2M. EPS beat the consensus estimate of $-0.01 by $0.03.
How did Xtant Medical Holdings's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 18.3% from $29.9M a year earlier.
Where can I find Xtant Medical Holdings's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001641172-25-023109) and the 10-Q periodic report (0001641172-25-023120) directly on SEC EDGAR. The filing index links above go to sec.gov.